130 related articles for article (PubMed ID: 26713412)
21. Sessile serrated adenoma/polyps: Where are we at in 2016?
Singh R; Zorrón Cheng Tao Pu L; Koay D; Burt A
World J Gastroenterol; 2016 Sep; 22(34):7754-9. PubMed ID: 27678358
[TBL] [Abstract][Full Text] [Related]
22. KRAS mutations in traditional serrated adenomas from Korea herald an aggressive phenotype.
Kim KM; Lee EJ; Kim YH; Chang DK; Odze RD
Am J Surg Pathol; 2010 May; 34(5):667-75. PubMed ID: 20305537
[TBL] [Abstract][Full Text] [Related]
23. Origin of colorectal cancers in hyperplastic polyps and serrated adenomas: another truism bites the dust.
Hamilton SR
J Natl Cancer Inst; 2001 Sep; 93(17):1282-3. PubMed ID: 11535695
[No Abstract] [Full Text] [Related]
24. Non-conventional dysplasia in inflammatory bowel disease is more frequently associated with advanced neoplasia and aneuploidy than conventional dysplasia.
Lee H; Rabinovitch PS; Mattis AN; Lauwers GY; Choi WT
Histopathology; 2021 May; 78(6):814-830. PubMed ID: 33155325
[TBL] [Abstract][Full Text] [Related]
25. Findings in the distal colorectum are not associated with proximal advanced serrated lesions.
Kahi CJ; Vemulapalli KC; Snover DC; Abdel Jawad KH; Cummings OW; Rex DK
Clin Gastroenterol Hepatol; 2015 Feb; 13(2):345-51. PubMed ID: 25083562
[TBL] [Abstract][Full Text] [Related]
26. The stem cell marker CD133 is highly expressed in sessile serrated adenoma and its borderline variant compared with hyperplastic polyp.
Mohammadi M; Bzorek M; Bonde JH; Nielsen HJ; Holck S
J Clin Pathol; 2013 May; 66(5):403-8. PubMed ID: 23436931
[TBL] [Abstract][Full Text] [Related]
27. [Serrated, hyperplastic and hyperplasia-like colorectal polyps].
Folker MB; Bernstein IT; Holck S
Ugeskr Laeger; 2006 Nov; 168(46):4005-9. PubMed ID: 17125655
[TBL] [Abstract][Full Text] [Related]
28. Demographic and pathological characteristics of serrated polyps of colorectum.
Higuchi T; Sugihara K; Jass JR
Histopathology; 2005 Jul; 47(1):32-40. PubMed ID: 15982321
[TBL] [Abstract][Full Text] [Related]
29. hMLH1 promoter methylation status causes different expression patterns of estrogen receptor protein with endometrial lesion progression.
Nishijima Y; Yoshida T; Nakamura K; Fukuda T
Rinsho Byori; 2013 Feb; 61(2):97-103. PubMed ID: 23672086
[TBL] [Abstract][Full Text] [Related]
30. The serrated neoplasia pathway of colorectal tumors: Identification of MUC5AC hypomethylation as an early marker of polyps with malignant potential.
Renaud F; Mariette C; Vincent A; Wacrenier A; Maunoury V; Leclerc J; Coppin L; Crépin M; Van Seuningen I; Leteurtre E; Buisine MP
Int J Cancer; 2016 Mar; 138(6):1472-81. PubMed ID: 26476272
[TBL] [Abstract][Full Text] [Related]
31. Sessile serrated adenoma with early neoplastic progression: a clinicopathologic and molecular study.
Fujita K; Yamamoto H; Matsumoto T; Hirahashi M; Gushima M; Kishimoto J; Nishiyama K; Taguchi T; Yao T; Oda Y
Am J Surg Pathol; 2011 Feb; 35(2):295-304. PubMed ID: 21263251
[TBL] [Abstract][Full Text] [Related]
32. [Wif-1 methylation and β-catenin expression in colorectal serrated lesions].
Fang Y; Wang L; Zhang Y; Ge C; Xu C
Zhonghua Bing Li Xue Za Zhi; 2014 Jan; 43(1):15-9. PubMed ID: 24713243
[TBL] [Abstract][Full Text] [Related]
33. Promoter methylation status of the MGMT, hMLH1, and CDKN2A/p16 genes in non-neoplastic mucosa of patients with and without colorectal adenomas.
Ye C; Shrubsole MJ; Cai Q; Ness R; Grady WM; Smalley W; Cai H; Washington K; Zheng W
Oncol Rep; 2006 Aug; 16(2):429-35. PubMed ID: 16820927
[TBL] [Abstract][Full Text] [Related]
34. Usefulness of the Japan narrow-band imaging expert team classification system for the diagnosis of sessile serrated lesion with dysplasia/carcinoma.
Murakami T; Sakamoto N; Fukushima H; Shibuya T; Yao T; Nagahara A
Surg Endosc; 2021 Aug; 35(8):4528-4538. PubMed ID: 32909209
[TBL] [Abstract][Full Text] [Related]
35. A Historical Perspective and Exposé on Serrated Polyps of the Colorectum.
Choi EY; Appelman HD
Arch Pathol Lab Med; 2016 Oct; 140(10):1079-84. PubMed ID: 27684980
[TBL] [Abstract][Full Text] [Related]
36. Clinical, pathologic, and outcome study of hyperplastic and sessile serrated polyps in inflammatory bowel disease.
Shen J; Gibson JA; Schulte S; Khurana H; Farraye FA; Levine J; Burakoff R; Cerda S; Qazi T; Hamilton M; Srivastava A; Odze RD
Hum Pathol; 2015 Oct; 46(10):1548-56. PubMed ID: 26297256
[TBL] [Abstract][Full Text] [Related]
37. UK guidance for the pathological reporting of serrated lesions of the colorectum.
Bateman AC; Shepherd NA
J Clin Pathol; 2015 Aug; 68(8):585-91. PubMed ID: 25934843
[TBL] [Abstract][Full Text] [Related]
38. Single-cell Transcriptomics Reveals Early Molecular and Immune Alterations Underlying the Serrated Neoplasia Pathway Toward Colorectal Cancer.
Zhou YJ; Lu XF; Chen H; Wang XY; Cheng W; Zhang QW; Chen JN; Wang XY; Jin JZ; Yan FR; Chen H; Li XB
Cell Mol Gastroenterol Hepatol; 2023; 15(2):393-424. PubMed ID: 36216310
[TBL] [Abstract][Full Text] [Related]
39. Clinical and endoscopic predictors of cytological dysplasia or cancer in a prospective multicentre study of large sessile serrated adenomas/polyps.
Burgess NG; Pellise M; Nanda KS; Hourigan LF; Zanati SA; Brown GJ; Singh R; Williams SJ; Raftopoulos SC; Ormonde D; Moss A; Byth K; P'Ng H; McLeod D; Bourke MJ
Gut; 2016 Mar; 65(3):437-46. PubMed ID: 25731869
[TBL] [Abstract][Full Text] [Related]
40. Microsatellite instability in inflammatory bowel disease-associated neoplastic lesions is associated with hypermethylation and diminished expression of the DNA mismatch repair gene, hMLH1.
Fleisher AS; Esteller M; Harpaz N; Leytin A; Rashid A; Xu Y; Liang J; Stine OC; Yin J; Zou TT; Abraham JM; Kong D; Wilson KT; James SP; Herman JG; Meltzer SJ
Cancer Res; 2000 Sep; 60(17):4864-8. PubMed ID: 10987299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
